Form D — Pelage Pharmaceuticals, Inc.
0001982875-25-000002 · filed Nov 24, 2025
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Reported offering amount
- $119,999,987
- Reported amount sold
- $119,999,987
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Pelage Pharmaceuticals, Inc.
- CIK
- 1982875
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 907 WESTWOOD BLVD #384
LOS ANGELES, CA 90024 - Phone
- 949-244-9904
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Daniel Gil · Executive OfficerLos Angeles, CA Find on LinkedIn ↗
-
William Edward Lowry · Executive OfficerLos Angeles, CA Find on LinkedIn ↗
-
Nathan Wheeler · Executive OfficerLos Angeles, CA Find on LinkedIn ↗
-
Cathy Friedman · DirectorLos Angeles, CA Find on LinkedIn ↗
-
Richard Heyman · DirectorLos Angeles, CA Find on LinkedIn ↗
-
Christina Weng · Executive OfficerLos Angeles, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗